1 / 28

MUSCULAR DYSTROPHIES Characteristics: 1-slowly progressive

MUSCULAR DYSTROPHIES Characteristics: 1-slowly progressive 2-myopathy(EMG-clinic-patholo. 3-no metabolic storage 4-symptoms are due to weakne. 5-hereditable 6-specific muscular weakness? 7-no treatment CLASSIFICATION : Duchenne MD-FSHMD- Dystrophia Myatonica.

israel
Download Presentation

MUSCULAR DYSTROPHIES Characteristics: 1-slowly progressive

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MUSCULAR DYSTROPHIES Characteristics: 1-slowly progressive 2-myopathy(EMG-clinic-patholo 3-no metabolic storage 4-symptoms are due to weakne

  2. 5-hereditable 6-specific muscular weakness? 7-no treatment CLASSIFICATION: Duchenne MD-FSHMD- Dystrophia Myatonica

  3. Differentiation : age-distribution of weakness-elevation of CK-speed of progression-hypertrophy Laboratory Diagnosis: EMG-Biopsy-DNA Analysis every myopathy----ECG-Serum CK

  4. x linked Muscular Dystrophies: Duchenne MD: incidence:1/3500 1/3 new mutation prevalence:1/18000 female: carrier beginning of symptims:3-5years

  5. deleyed of walking-toe walking- waddeling gait-Gowers sign- hyperlordosis-facial weakness- intactness of eye movement& speech&swallowing-scoliosis- contracture of iliotibalis&knee&arm

  6. impairment of breathing-clinical intactness of heart&GI-MR(1/3)- D.D:SMA Becker MD :Incidence 1/20000 hyper CK emia-hypertrophy of calf EMG&Pathology=Duchenne “”&

  7. Age of beginning:12 years slower progressive than Duchenn D.D:SMA-Acid maltase deficiency- Phosphorilase deficiency- Carriers-Idiopathic hyperCKemi -Hepatitis

  8. TREATMENT :Prednisolone Creatin -Myoblast Brace-surgery-PT- Supporting-Heart graft EMERY DERIFUSS M.D: 1-Humeroproneal weakness

  9. 2-Contracture of knee &elbow &fingers & anckle 3-heart block (pacemaker ) 4-xq28 FSH MD: adolecent-AD-normal CK Chromosome 4-

  10. Symptoms :1-facial weakness 2-winging of scapula 3-weakness of trapezius 4-biceps weaker triceps 5-Popey effect (upper arm is thinner forearm) 6-leg weakness

  11. Prognosis :slow progressive Laboratory findings: EMG &Biopsy----Myopathy serum CK-----normal ECG-----------normal Treatment: Symptomatic-Albuterol (B2 adrenergic)-wiring ;

  12. MYASTHENIA GRAVIS; 1-Juvenil&Adult:2th-4thdecade anti Ach R---85% Seronegative ---- prepuberty 2-Neonatal MG----12%neonates floppy limbs-weakened cry - sucking is impaired

  13. Mothers are sick-presence of Ab in both-improvement after weeks Congenital MG: Mother is asymptomatic Ophthalmoplegia-No Ab Weakness of extensors

  14. Drug induced MG: Penicillamin Trimethadion Pathology: Hyperplasia of thymus( 70%)-thymoma(10%) local invasive &old age -Lymphorrhagia(50%)

  15. Incidence:<40years F/M=3/1 >40years F=M Prevalence:14/100000 Familial (rarely) HLA B8-DR3-DQB1 HLA A12(Japan ) SLE-RA-Thyroid disease

  16. Symptoms:1-flactuation of weakness remission & exacerbation Crisis 2-Distibution of weakness Eye muscles 40-85% Dysarthria - Dysphagia- Weakness of facial

  17. ---Symptoms; limbs &cervical weak crisis 3-Response to cholinergic drugs MG is limited (ocular MG for 2years) Mortality :rarely

  18. Signs: PE&VS are normal expressionless face-INO Limb weakness- ptosis- - diplopia PFT disturbance-wastng(10% normal DTR&Sensory

  19. Laboratory Findings: Normal (U/A-Serum-CSF)Routin Jolly test 90% abnormal MEP decreased(20% of normal) SFEMG---increase of jitter (blocking) NCV&EMG---Normal 7

  20. Ab—Generalized 85-90% positive Ocular 50-60% positive Antimyofibrilar(Titin-myosin-actin- actomyosin)85% 5%hyperthyroidism CXR oblique 15%positive(thymom

  21. CT scan of mediastina 100%positiv Diagnosis:Tensilon&prostigmin test TREATMENT: 1-Anticholinstrase 2-Plasmaphresis 3-Thymectomy 4-Steroids 5-Immunosupressive

  22. Polymyositis Disorder of skeletal muscle of diverse causes --- acute or sub acute onset Clinical Manifestation : progressive limb and neck muscles weakness – distal M are usually affected later – eyelids & ocular movements spared– dysphagia usually without disarthria

  23. Systemic symptoms not evident -arthralgia – weight loss - Malaise Raynaud symptoms- no rash of DM –no visceral lesion –myocarditis may accure –may persist for years Laboratory data : EMG myopathic no fasciculation –NCV normal –CK 10 times Biopsy:CD8 Tlymphocyte muscle

  24. Pathogenesis : autoimmune disease (cellular) association of PM with Crohn –biliary cirrhosis sarcoidosis –MG with thymoma and candidiasis – graft versus host disease – HIV &HTLV1 viral disease Diagnosis : 1) no familial history 2) progress from onset peak weeks or months 3) >35 y 4)may improve spontaneusly or with therapy 5)proximal and neck weakness &dysphagia

  25. 6)Arthralgia .myalgia and Raynaud symptoms 7)EMG findings D D : PM with DM --- 1) DM most often homogeneus condition only rarely associated with a known cause other than carcinoma . PM 50% associated with some other systemic dis 2) PM is often a manifestation of a specific collagen vascular disease ( SLE ,,,,, ) DM rarely associated with collagen disease

  26. 3) DM ocure at all ages ; PM is rare before puberty 4)myopathy of DM is sever more often than PM 5) DM is far more likely to be associated with malignancy than PM Therapy : Steroids -- immunosuppressive IVIG --Infliximab

More Related